Methylene Blue , ASHP Drug Shortage Detail (id=47) (2020)

Other · American Society of Health-System Pharmacists · January 13, 2020

American Society of Health-System Pharmacists, 2020-01-13: ASHP's shortage record for methylene blue, last revised 13 January 2020, states that Akorn had no plans to manufacture methylene blue and lists ProvayBlue (American Regent, 5 mg/mL 10 mL ampule) as the available product.

Reason for the Shortage Akorn has no current plans on manufacturing methylene blue.[1] Available Products ProvayBlue injection, American Regent, 5 mg/mL, 10 mL ampule, 5 count, NDC 00517-0374-01

American Society of Health-System Pharmacists, 2020-01-13: ASHP's shortage record for methylene blue, last revised 13 January 2020, states that Akorn had no plans to manufacture methylene blue and lists ProvayBlue (American Regent, 5 mg/mL 10 mL ampule) as the available product. C10 , ASHP, 'Methylene Blue', shortage detail id=47, revision date 1/13/2020, date first listed 2015-06-08 (per the ASHP current-shortage list). Route: ashp.org returns a Cloudflare 403 to scripts, so the page was read from the Internet Archive capture of 2025-04-18. The list page capture of 2026-11-15 shows the row 'Methylene Blue | Jan 13, 2020 | Jun 08, 2015' under current shortages. Excerpt is contiguous across the 'Reason for the Shortage' and 'Available Products' headings. Study type: other.